Vir Biotechnology, Inc. (BX:VIR) Financings
Financings
| Raise | Date |
|---|---|
| Public offering of common stock Announced: US$150M · US$10 a share · Leerink Partners +3 Dealers: Leerink Partners (co-lead), Morgan Stanley (co-lead), Evercore ISI (co-lead), Raymond James | Nov 13, 2026 |
| Strategic investment of equity Announced: US$25M Buyers: Gilead ($25 million equity investment at a 30% premium) | Oct 14, 2026 |
| Strategic investment of shares Closed: US$75M raised · US$10.36 a share Buyers: Astellas ($75 million equity investment at a price of $10.36 per share) | Apr 16, 2026 |
| Public offering of common stock Terms changed: US$150M · US$8.5 a share · Goldman Sachs & Co. LLC +3 Dealers: Goldman Sachs & Co. LLC (co-lead), Leerink Partners (co-lead), Evercore ISI (co-lead), Barclays (co-lead) | Feb 26, 2026 |